ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Science

Nobel laureate has high hopes for donor iPS cells

Latest trial could pave way for cheaper, faster treatment, says Shinya Yamanaka

Shinya Yamanaka hopes a recent transplant involving donor-derived iPS cells will lead to the widespread use of regenerative treatments.

KYOTO A team of Japanese doctors recently performed a landmark surgery involving the use of donated induced pluripotent stem, or iPS cells, to treat macular degeneration, an intractable eye disease.

The operation, which used cells gathered and prepared ahead of time, was performed at Kobe City Medical Center General Hospital as part of a joint project also involving researchers from Riken and Kyoto University's Center for iPS Cell Research and Application, or CiRA.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more